HYPR:NASDAQ, Hyperfine, Inc.
HYPR stock overview
Hyperfine, Inc. (HYPR:NASDAQ) closed at $0.718 on October 30, 2026,
down 3.50% on the day.
The stock trades 62.9% below its 52-week high of $1.94
and 3.1% above its 52-week low of $0.696.
Over the past year, it lost 35.9%.
Hyperfine, Inc. is part of the Health Care sector.
Key figures
- Price
- $0.718
- Day change
- -3.50%
- Volume
- 564,764
- Average volume
- 734,992
- Market cap
- 76M+
- 52-week range
- $0.696 – $1.94
- 50-day average
- $0.816
- 200-day average
- $1.13
Price action over the past year
In 252 trading sessions since October 30, 2025, HYPR closed higher on 103 days (41%).
Its best day was June 25, 2026 (+15.75%) and its worst was June 26, 2026 (-13.02%).
The stock moved 10% or more in a single session 10 times.
It opened at least 5% above the previous day's high 1 time.
Recent signals
HYPR news
-
Oct 22, 2026:
Hyperfine Advances International Swoop System Model 2 Rollout and Highlights the Role of Portable MRI in Brain Health Awareness
-
Oct 8, 2026:
Hyperfine Reports Record Preliminary Q3 Revenue of $6 Million, Up 53% Sequentially
-
Oct 8, 2026:
Hyperfine Reports Record Preliminary Third Quarter Revenue of Approximately $6.0 Million & Reaffirms Full Year 2026 Revenue Outlook of Approximately $20 to $22 Million
-
Oct 8, 2026:
Hyperfine, Inc. to Announce Third Quarter 2026 Financial Results on November 9, 2026
-
Sep 28, 2026:
Hyperfine Expands Global Access to Portable Brain MRI Technology Across Key Gulf Cooperation Council Healthcare Markets
-
Sep 16, 2026:
MedtechWOMEN Names Hyperfine CEO Maria Sainz Winner of 2026 Ferolyn Powell Leadership Award
-
Sep 15, 2026:
Hyperfine Announces Completion of Enrollment in the Contrast PMR Study to Support the Submission to Expand Indications for Use of the Swoop System with Contrast Agents
-
Sep 15, 2026:
Hyperfine Announces Completion of Enrollment in the Contrast PMR Study to Support the Submission to Expand Indications for Use of the Swoop® System with Contrast Agents
About Hyperfine, Inc.
Hyperfine Inc is a medical device company that created Swoop, a portable MRI system. It has designed Swoop to enable rapid diagnoses and treatment for every patient regardless of income, resources, or location, pushing the boundaries of conventional imaging technology and expanding patient access to life-saving care. The Swoop Portable MR Imaging System produces images at a lower magnetic field strength, allowing clinicians to quickly scan, diagnose and treat patients in various clinical settings.
Similar stocks
Find more stocks like HYPR with the
Spikes,
Gaps,
Breakouts and
Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.